Breathing New Life Into IPF – How AI is Changing the Game

Despite extensive research, treating idiopathic pulmonary fibrosis (IPF) and managing therapy side effects remain challenging. Clinical trials for IPF face issues like accurate diagnosis, recruitment complexities, and endpoint limitations. Recent advances in AI for lung scan evaluation can enhance diagnosis and ongoing lung health monitoring, including cough and fibrosis.